Net profit of Astrazeneca Pharma India rose 5.64% to Rs 32.59 crore in the quarter ended December 2025 as against Rs 30.85 crore during the previous quarter ended December 2024. Sales rose 38.90% to Rs 611.57 crore in the quarter ended December 2025 as against Rs 440.29 crore during the previous quarter ended December 2024.
| Particulars | Quarter Ended |
| Dec. 2025 | Dec. 2024 | % Var. |
| Sales | 611.57 | 440.29 | 39 |
| OPM % | 7.33 | 17.49 | - |
| PBDT | 48.90 | 84.64 | -42 |
| PBT | 45.06 | 75.57 | -40 |
| NP | 32.59 | 30.85 | 6 |